Navigation Links
Par Pharmaceutical Companies Reports Third Quarter 2011 Results
Date:11/2/2011

WOODCLIFF LAKE, N.J., Nov. 2, 2011 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today reported results for the third quarter ended September 30, 2011.

For the third quarter ended September 30, 2011, the Company reported total revenues of $215.4 million, and income from continuing operations of $22.1 million, or $0.60 per diluted share, which includes $2.9 million of acquisition-related expenses.  Excluding this item and associated tax impacts, adjusted income from continuing operations (non-GAAP measure) was $25.5 million. On an adjusted cash basis (non-GAAP measure), which excludes amortization expenses, income from continuing operations was $27.1 million, or $0.74 per diluted share for the third quarter 2011. (Please see attached reconciliation page.)  This is compared to reported revenues of $234.4 million and adjusted cash basis income from continuing operations of $31.3 million, or $0.88 per diluted share for the same period in 2010.

For the nine months ended September 30, 2011, the Company reported total revenues of $672.5 million and a loss of $77.6 million from continuing operations, or $2.17 per diluted share, as a result of a $190.6 million pre-tax litigation settlement expense in the first quarter, second quarter restructuring charges of $27.7 million, and the aforementioned transaction costs.  On an adjusted cash basis (non-GAAP measure), income from continuing operations was $92.9 million, or $2.54 per diluted share.  This compares to reported revenues of $781.8 million and income from continuing operations of $75.1 million, or $2.12 diluted share, for the same period in 2010.  On an adjusted cash basis, income from continuing operations for the first nine months of 2010 was $82.7 million, or $2.34 per diluted share.

The following is a product level discussion of third quarter 2011 results versus the
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Aug. 28, 2015  CytomX Therapeutics, Inc., a biopharmaceutical ... today announced the filing of a registration statement on ... (SEC) relating to a proposed initial public offering of ... offered and the price range for the offering have ... common stock under the symbol "CTMX" on the NASDAQ ...
(Date:8/28/2015)... Research and Markets ( ... "Investigation Report on China,s Bevacizumab Market ,2010-2019" report ... the trade name of Avastin, bevacizumab injection is the ... it was approved by CFDA to treat metastatic colorectal ... all come from Roche and its subsidiary ...
(Date:8/28/2015)... 28, 2015  Today, in final recognition of the ... Health Week, 1-800 Contacts is sharing how to keep ... lens wearers who do not properly care for their ... infections. Most contact lens wearers understand ... clean lens case is sometimes overlooked.  When proper steps ...
Breaking Medicine Technology:CytomX Files Registration Statement for Proposed Initial Public Offering 2Investigation Report on China's Bevacizumab Market 2015-2019 21-800 Contacts Shares Tips on How to Clean Lens Cases 2
... Reportlinker.com announces that a new market ... Stakeholder Opinions: Vaccines in ... Brazil, Mexico and Argentina ... the past decade, vaccines have resurfaced as ...
... Md., Nov. 4, 2010 The U.S. Food and ... pathway to market for mammography systems that produce computerized ...   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) (Logo:   http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) ... Digital Mammography Systems, are an alternative to mammography systems ...
Cached Medicine Technology:Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 2Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 3Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 4Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 5Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 6Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 7Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 8FDA Reclassifies Certain Digital Mammography Devices 2FDA Reclassifies Certain Digital Mammography Devices 3
(Date:8/30/2015)... ... August 31, 2015 , ... ... third of tax receipts, issues that are critically important to them are often ... attorneys and lobbyists monitoring proposed legislation and changing tax and regulatory policies. Smaller ...
(Date:8/30/2015)... ... August 30, 2015 , ... ... announce that Partner Daniel M. Kotin was recently elected to membership in the ... the highest degree of peer recognition and outstanding professionalism. , ABOTA is ...
(Date:8/30/2015)... ... 2015 , ... Natural Rest contains a unique mixture of vitamins and herbs ... which help to improve mood disorders and anxiety. Like all other Creative Medical Health ... field of regenerative medicine conducted by Dr. Amit Patel of the University of Utah, ...
(Date:8/29/2015)... ... , ... Rio Salado College President Chris Bustamante announced on Aug. ... Strategic Initiatives and Information Services. O’Shea, who has served Rio Salado for the last ... impact through innovative technologies and strategies. , “I am very proud to be able ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... scrotal support and protection against dribbled urine and sweat. "In order to prevent ... N.Y. , The EASY ACCESS DRYNESS ENHANCED MEN'S UNDERGARMENT provides optimal support for ...
Breaking Medicine News(10 mins):Health News:Newport Board Group, an Advisory Firm Serving the Middle Market, Issues Five Tips on Selling Services to the Government 2Health News:Newport Board Group, an Advisory Firm Serving the Middle Market, Issues Five Tips on Selling Services to the Government 3Health News:Newport Board Group, an Advisory Firm Serving the Middle Market, Issues Five Tips on Selling Services to the Government 4Health News:Chicago Personal Injury Lawyer Daniel M. Kotin Elected to the American Board of Trial Advocates 2Health News:Chicago Personal Injury Lawyer Daniel M. Kotin Elected to the American Board of Trial Advocates 3Health News:Creative Medical Health’s Natural Rest® Now Available on ReCreative Medical Health’s Natural Rest® Now Available on RevNutrition.com 2Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2Health News:Modified Men’s Underwear Promote More Comfort and Hygiene - Designed by InventHelp Client (LGI-1968) 2
... for its high standards in nursing quality, today announced the ... excellence. The honor is determined by the American Nurses ... best in patient care. The ANCC notified Northwestern Memorial ... status sets our hospital apart and places us amongst a ...
... conducting basic research on ion channels have demonstrated a ... pain., Targeting these ion channels pharmacologically would offer effective ... painkilling drugs, according to their paper, published in a ... is the most common symptom of injuries and diseases, ...
... -- Among people with rheumatoid arthritis, 11 percent of those ... had been seeing one for quite a while. In ... other medical words related to rheumatoid arthritis, such as "osteoporosis" ... noted that previous findings have suggested that low levels of ...
... stop unwanted intruders, the skin serves as a barrier protecting ... microbes people come in contact with every day. In patients ... skin disease, the skin barrier is leaky, allowing intruders ... be sensed by the skin and subsequently wreak havoc on ...
... By Steven Reinberg HealthDay Reporter , ... percent of American adults say they had difficult childhoods ... who were absent due to separation or divorce, federal ... said that while growing up they underwent five or ...
... Social Graph app, researchers in the ADVANCE project at ... to help women scientists and engineers supercharge their careers. ... balance sheets. They,re webs of human interaction," said Nancy ... Technology and the ADVANCE project leader. "The complex structure ...
Cached Medicine News:Health News:Northwestern Memorial maintains top status in nursing hospital renewed for Nurse Magnet® 2Health News:Ion channel responsible for pain identified by UB neuroscientists 2Health News:Patient Literacy Problems Can Hinder Rheumatoid Arthritis Care 2Health News:Study reveals major shift in how eczema develops 2Health News:Study reveals major shift in how eczema develops 3Health News:Majority of U.S. Adults Had Troubled Childhoods: CDC 2Health News:Majority of U.S. Adults Had Troubled Childhoods: CDC 3Health News:Mapping faculty social networks helps female faculty move ahead at NJIT 2Health News:Mapping faculty social networks helps female faculty move ahead at NJIT 3
... this is the universal lithotripter for ... urinary and biliary treatment. The system ... with other applications including cystoscopy, ureteronoscopy, ... system comprises the height adjustable urologist' ...
... This therapeutic system ... the patient in mind. ... surgery and ongoing therapy, ... low-risk and effective therapy. ...
... Reach a new dimension! That of the ... unequalled performance and ease of use. Enjoy ... electroconductive shock wave technology coupled with the ... system. Manage the patient treatment, X-ray and ...
... The MINILITH SL1 developed by STORZ ... of extensive experience in the field of ... of the specific requirements to be met ... therapy, as has been outlined above. The ...
Medicine Products: